s6y
Company name or ticker
Search
AEON Biopharma, Inc.
3
LYNCH TIMOTHY P: Initial statement of beneficial ownership of securities
Filed
Friday, August 21, 2026
Period
Aug 19, 2026
Accession number
0000935836-26-000438
Documents
FORM 3
3
On sec.gov
Filing index
All files
Complete submission text
SGML header